Skip to main content
All lobbying filings

HIV AND HEPATITIS POLICY INSTITUTE

HIV AND HEPATITIS POLICY INSTITUTE filed a Q3 report for HIV AND HEPATITIS POLICY INSTITUTE on October 17, 2025.

Lobbying for HIV AND HEPATITIS POLICY INSTITUTE · Patient advocacy

All filings by HIV AND HEPATITIS POLICY INSTITUTE · Everything HIV AND HEPATITIS POLICY INSTITUTE has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 17, 2025
Expenses
$10,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 7

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 4
Budget/Appropriations

CDC domestic HIV and hepatitis prevention, Ryan White Comprehensive AIDS Resources Emergency (CARE) Act programs, Ending the HIV Epidemic Initiative, including PrEP activities for community health centers, Minority AIDS Initiative, and NIH AIDS research

Health Issues

HIV Prevention Now Act (HR 5126); PrEP & PEP are Prevention Act (HR 5127); National PrEP Program

Insurance

Preventive Service insurance coverage for PrEP, Copay Assistance & Cost sharing for prescription drugs, Essential Health Benefits & Prescription Drugs

Pharmacy

Preventive Service coverage for PrEP, Copay Assistance & Cost sharing for prescription drugs; Essential Health Benefits & Prescription Drugs

 Bills named in this filing 2

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem